-
BMW boosts profitability, welcomes Nexperia signals
-
EU strikes last-ditch deal on climate targets as COP30 looms
-
Stocks retreat as tech bubble fears grow
-
Shein opens first permanent store amid heavy police presence
-
West Indies edge New Zealand despite Santner brilliance
-
French pair released by Iran await return home
-
German factory orders up but outlook still muted
-
Death toll tops 100 as Philippines digs out after typhoon
-
Attack on key city in Sudan's Kordofan region kills 40: UN
-
'No one could stop it': Sudanese describe mass rapes while fleeing El-Fasher
-
Champagne and cheers across New York as Mamdani soars to victory
-
Medieval tower collapse adds to Italy's workplace toll
-
BMW boosts profitability despite China, tariff woes
-
South Africa's Wiese wary of 'hurt' France before re-match
-
Asian markets sink as tech bubble fears grow
-
Beyond limits: Croatian freediver's breathtaking record
-
Tottenham supporting Udogie after alleged gun threat in London
-
Thunder roll Clippers to stay unbeaten as SGA keeps streak alive
-
In appeal, Australian mushroom murderer alleges 'miscarriage of justice'
-
Toyota hikes profit forecasts 'despite US tariffs'
-
Typhoon death toll soars past 90 in the Philippines
-
Ex-France lock Willemse challenges Meafou to become 'the bully'
-
Ukrainians to honour sporting dead by building country they 'died for': minister
-
At least 7 dead after UPS cargo plane crashes near Louisville airport
-
US Supreme Court hears challenge to Trump tariff powers
-
US government shutdown becomes longest in history
-
India's Modi readies bellwether poll in poorest state
-
Green goals versus growth needs: India's climate scorecard
-
Where things stand on China-US trade after Trump and Xi talk
-
Sri Lanka targets big fish in anti-corruption push
-
NY elects leftist mayor on big election night for Democrats
-
Injured Jordie Barrett to miss rest of All Blacks tour
-
Asian markets tumble as tech bubble fears grow
-
Pay to protect: Brazil pitches new forest fund at COP30
-
Australia pick 'impressive' Weatherald in first Ashes Test squad
-
Iraq's social media mercenaries dying for Russia
-
Young leftist Trump foe elected New York mayor
-
Concerns at ILO over expected appointment of close Trump advisor
-
Venus Williams to return to Auckland Classic at the age of 45
-
No deal yet on EU climate targets as COP30 looms
-
Typhoon death toll climbs to 66 in the Philippines
-
NATO tests war preparedness on eastern flank facing Russia
-
Uncapped opener Weatherald in Australia squad for first Ashes Test
-
Liverpool down Real Madrid in Champions League, Bayern edge PSG
-
Van Dijk tells Liverpool to keep calm and follow Arsenal's lead
-
PSG left to sweat on injuries to Dembele and Hakimi
-
Reddit, Kick to be included in Australia's social media ban
-
Ex-Zimbabwe cricket captain Williams treated for 'drug addiction'
-
Padres ace Darvish to miss 2026 MLB season after surgery
-
Diaz hero and villain as Bayern beat PSG in Champions League showdown
No-prescription birth control pills soon available in US pharmacies
Prescription-free birth control pills will be available across the United States later this month, widening access to contraception at a time when abortion rights have been drastically curtailed.
American-Irish maker Perrigo Company announced Monday that its Opill has "shipped to major retailers and pharmacies and will be available on shelves nationwide," available in one-month and three-month packs for $19.99 and $49.99 respectively. It will also be available on Opill.com.
Over-the-counter (OTC) birth control has long been backed by major medical organizations as a way to reduce barriers to contraception access, with more than 6.1 million births in the US each year unintended, according to official data.
"We champion the right of women and people to determine their own sexual health journey and the availability of Opill over-the-counter is truly a historic moment of which our entire organization can be proud," said Perrigo Executive Vice President Triona Schmelter.
Opill, which was cleared last year by the Food and Drug Administration for sale without prescription, is known as a "mini pill" because it contains progestin only, and works by thickening mucus in the cervix to stop sperm reaching an egg.
Preserving access to contraception has proven politically divisive following the conservative-led Supreme Court's decision to revoke the national right to abortion in 2022.
Twenty-one states banned or moved to restrict abortions to limits tighter than before Roe v Wade, the case law that previously upheld the constitutional right to terminate a pregnancy.
Republicans in Congress also blocked Democrat-backed legislation that would have codified individuals' right to access contraception, an issue that has taken on more urgency as conservative-run states define personhood in new ways.
Alabama's top court last month said that frozen embryos should be considered children, though the state's legislature quickly moved to pass a bill protecting clinics from legal liability if such embryos were inadvertently damaged or destroyed.
Over-the-counter birth control is backed by major medical organizations, including the American College of Obstetricians and Gynecologists (ACOG), the American Medical Association and the American Academy of Family Physicians.
Much of Asia, Africa and Latin America allow OTC birth control. The UK joined the club in 2021, but prescriptions are still required in much of mainland Europe including France, Germany, Spain and Italy, according to "Free the Pill" which tracks the issue.
P.Tamimi--SF-PST